My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Cipla drops after unfavorable ruling by Supreme Court
Oct 21,2016

The announcement was made during market hours today, 21 October 2016.

Meanwhile, the S&P BSE Sensex was down 54.24 points or 0.19% at 28,075.60

On BSE, so far 1.53 lakh shares were traded in the counter as against average daily volume of 2.08 lakh shares in the past one quarter. The stock hit a high of Rs 596.50 and a low of Rs 570.30 so far during the day. The stock had hit a 52-week high of Rs 704.75 on 29 October 2015. The stock had hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had outperformed the market over the past 30 days till 20 October 2016, falling 0.86% compared with 1.32% fall in the Sensex. The scrip also outperformed the market in past one quarter, gaining 14.5% as against Sensexs 1.17% rise.

The large-cap company has equity capital of Rs 160.84 crore. Face value per share is Rs 2.

Cipla said that Supreme Court has today, 21 October 2016 decided in favour of Union of India in an appeal filed against the company and others arising out of the judgement of the Allahabad High Court. The other petitions filed in the Bombay High Court on completely separate sets of grounds relating to alleged overcharged amounts are pending and are still subject to the interim stay granted by the Supreme Court in July 2016, Cipla said. The ruling was with reference to pending legal cases relating to alleged overcharging in respect of certain drugs under the Drugs (Price Control) Order, 1995.

On a consolidated basis, Cipla reported 43.7% fall in net profit to Rs 365.24 crore on 6.9% decline in net sales to Rs 3499.81 crore in Q1 June 2016 over Q1 June 2015.

Cipla is a global pharmaceutical company

Powered by Capital Market - Live News

Disappointing Q3 results drag lower ACC counter
Oct 21,2016

The result was announced during market hours today, 21 October 2016.

Meanwhile, the S&P BSE Sensex was down 64.43 points or 0.23% at 28,062.74.

More than usual volumes were witnessed on the counter. On BSE, so far 65,883 shares were traded in the counter as against average daily volume of 35,172 shares in the past one quarter. The stock hit high of Rs 1,618.75 and low of Rs 1,542 so far during the day. The stock hit a 52-week high of Rs 1,738 on 8 August 2016. The stock hit a 52-week low of Rs 1,173.25 on 29 February 2016. The stock had underperformed the market over the past one month till 20 October 2016, falling 1.42% compared with 1.38% decline in the Sensex. The scrip had also underperformed the market in past one quarter, declining 1.31% as against Sensexs 0.77% rise.

The large-cap company has equity capital of Rs 187.79 crore. Face value per share is Rs 10.

ACCs operating earnings before interest, taxes, depreciation and amortization (EBITDA) declined 12.61% to Rs 273.70 crore in Q3 September 2016 over Q3 September 2015. ACC said that the ongoing efforts to enhance operational efficiencies and tighten operating costs enabled some visible signs of improvements by way of optimisation of fuel mix with higher use of cheaper fuel like pet coke, optimization of the gypsum mix and lower input material costs. ACC said in its outlook that on the supply side, the company expects its volumes to pick up as the newly commissioned units stabilize, especially in the fast-growing eastern region. On the overall demand side, the company maintains an optimistic outlook for the economy in the coming months.

ACC is a manufacturer of cement and ready mixed concrete with a countrywide network of factories and sales offices.

Powered by Capital Market - Live News

ACC drops after reporting weak Q3 results
Oct 21,2016

The result was announced during market hours today, 21 October 2016.

Meanwhile, the S&P BSE Sensex was down 110.04 points or 0.39%at 28,023.63.

On BSE, so far 49,984 shares were traded in the counter as against average daily volume of 35,172 shares in the past one quarter. The stock hit high of Rs 1,618.75 and low of Rs 1,545.20 so far during the day. The stock hit a 52-week high of Rs 1,738 on 8 August 2016. The stock hit a 52-week low of Rs 1,173.25 on 29 February 2016. The stock had underperformed the market over the past one month till 20 October 2016, falling 1.42% compared with 1.38% decline in the Sensex. The scrip had also underperformed the market in past one quarter, declining 1.31% as against Sensexs 0.77% rise.

The large-cap company has equity capital of Rs 187.79 crore. Face value per share is Rs 10.

ACCs operating earnings before interest, taxes, depreciation and amortization (EBITDA) declined 12.61% to Rs 273.70 crore in Q3 September 2016 over Q3 September 2015. ACC said that on the supply side, the company expects its volumes to pick up as the newly commissioned units stabilize, especially in the fast-growing eastern region. On the overall demand side, the company maintains an optimistic outlook for the economy in the coming months.

ACC is a manufacturer of cement and ready mixed concrete with a countrywide network of factories and sales offices.

Powered by Capital Market - Live News

Nucleus Software Exports spurts after robust Q2 outcome
Oct 21,2016

The result was announced after market hours yesterday, 20 October 2016.

Meanwhile, the S&P BSE Sensex was down 150.46 points, or 0.53%, to 27,979.38

On BSE, so far 2.51 lakh shares were traded in the counter, compared with an average daily volume of 5,611 shares in the past one quarter. The stock hit a high of Rs 223.95 and a low of Rs 207 so far during the day. The stock hit a 52-week high of Rs 290.90 on 2 December 2015. The stock hit a 52-week low of Rs 145.20 on 29 February 2016. The stock had outperformed the market over the past 30 days till 20 October 2016, gaining 2.2% compared with 1.32% fall in the Sensex. The scrip, however, underperformed the market in past one quarter, falling 3.86% as against Sensexs 1.17% rise.

The small-cap company has an equity capital of Rs 32.38 crore. Face value per share is Rs 10.

Vishnu R. Dusad, CEO, Nucleus Software Exports said that the company saw continuing traction in cloud business and digital solutions in Q2 September 2016.

Nucleus Software Exports said that during the quarter, 10 product module implementations successfully went live across the globe. Cash and cash equivalents, including investments in debt schemes of mutual funds, fixed deposits with banks and tax free PSU bonds are at Rs 412.0 crore as on 30 September, 2016, as against Rs 342.6 crore on 30 September 2015.

Nucleus Software Exports is the leading provider of lending and transaction banking products to the global financial services industry.

Powered by Capital Market - Live News

Rane Engine Valve jumps on turnaround Q2 results
Oct 21,2016

The result was announced during market hours today, 21 October 2016.

Meanwhile, the S&P BSE Sensex was down 154.84 points or 0.55% at 27,975.

High volumes were witnessed on the counter. On BSE, so far 71,944 shares were traded in the counter as against average daily volume of 6,686 shares in the past one quarter. The stock hit a high of Rs 794 and a low of Rs 700.10 so far during the day. The stock hit a record high of Rs 807.45 on 15 September 2016. The stock hit a 52-week low of Rs 442 on 12 February 2016. The stock had outperformed the market over the past one month till 20 October 2016, rising 6.9% compared with 1.38% decline in the Sensex. The scrip had also outperformed the market in past one quarter, jumping 55.34% as against Sensexs 0.77% rise.

The small-cap company has equity capital of Rs 6.72 crore. Face value per share is Rs 10.

Rane Engine Valves total operating income rose 4% to Rs 90.70 crore in Q2 September 2016 over Q2 September 2015. Earnings before interest, taxes, depreciation and amortization (EBITDA) margin rose to 2.3% in Q2 September 2016 from 1.8% in Q2 September 2015.

L Ganesh, Chairman of Rane Group said that the company continued to improve its operational performance. The debottlenecking efforts to improve plant production helped it to capitalize on strong demand in select market segments. The company was able to reduce the operational loss with focused efforts on material cost reduction, and stringent fixed cost reduction. These initiatives will continue in the upcoming quarters to improve operational efficiency and deliver profitable growth.

Rane Engine Valve manufactures engine valves, valve guides and tappets for various IC engine applications.

Powered by Capital Market - Live News

Volumes jump at Nucleus Software Exports counter
Oct 21,2016

Nucleus Software Exports clocked volume of 2.34 lakh shares by 14:00 IST on BSE, a 33.44-times surge over two-week average daily volume of 7,000 shares. The stock jumped 14.02% to Rs 217.20.

Vardhman Textiles notched up volume of 51,000 shares, a 24.48-fold surge over two-week average daily volume of 2,000 shares. The stock declined 0.02% to Rs 1,088.

Cholamandalam Investment and Finance Company saw volume of 2.02 lakh shares, a 22.07-fold surge over two-week average daily volume of 9,000 shares. The stock rose 1.62% to Rs 1,204.

Caplin Point Laboratories clocked volume of 2.55 lakh shares, a 17.98-fold surge over two-week average daily volume of 14,000 shares. The stock surged 16.06% to Rs 407.95 after the company received Rs 35 crore in its wholly owned subsidiary Career Point Infra from Career Point University, Kota towards assets sale transaction. The announcement was made after market hours yesterday, 20 October 2016.

Carborundum Universal saw volume of 4.77 lakh shares, a 17-fold rise over two-week average daily volume of 28,000 shares. The stock declined 0.55% to Rs 282.50.

Powered by Capital Market - Live News

Career Point jumps after receiving Rs 35 crore for assets sale
Oct 21,2016

The announcement was made after market hours yesterday, 20 October 2016.

Meanwhile, the S&P BSE Sensex was down 107.99 points or 0.38% at 28,021.85

On BSE, so far 92,000 shares were traded in the counter as against average daily volume of 10,642 shares in the past one quarter. The stock hit a high of Rs 133.35 and a low of Rs 121 so far during the day. The stock had hit a 52-week high of Rs 160 on 2 December 2015. The stock had hit a 52-week low of Rs 94.50 on 17 February 2016. The stock had outperformed the market over the past 30 days till 20 October 2016, gaining 10.24% compared with 1.32% fall in the Sensex. The scrip also outperformed the market in past one quarter, advancing 1.68% as against Sensexs 1.17% rise.

The small-cap company has equity capital of Rs 18.13 crore. Face value per share is Rs 10.

Pramod Maheshwari, Chairman and Managing Director Career Point said that it was very strategic and vigilant decision for the company to enter in annuity driven formal education segment. The companys investments in formal education are being paid-off, Maheshwari said. At the same time, financing by the nationalized bank to the University indicates confidence in long-term prospects and financial steadiness of the University, he added.

On consolidated basis, Career Points net profit rose 2.17% to Rs 2.35 crore on 0.85% decline in total income to Rs 19.82 crore in Q1 June 2016 over Q1 June 2015.

Career Point caters to the needs of a student throughout the life cycle of a student (KG to PhD) while operating in both formal and informal education streams.

Powered by Capital Market - Live News

JSW Holdings drops after reporting dismal Q2 results
Oct 21,2016

The result was announced during market hours today, 21 October 2016.

Meanwhile, the S&P BSE Sensex was down 121.20 points or 0.43% at 28,008.64.

On BSE, so far 2,449 shares were traded in the counter as against average daily volume of 2,356 shares in the past one quarter. The stock hit a high of Rs 1,285.40 and a low of Rs 1,247.95 so far during the day. The stock hit a 52-week high of Rs 1,394 on 15 July 2016. The stock hit a 52-week low of Rs 930.50 on 23 November 2015. The stock had outperformed the market over the past one month till 20 October 2016, rising 0.56% compared with 1.38% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, dropping 3.41% as against Sensexs 0.77% rise.

The mid-cap company has equity capital of Rs 11.10 crore. Face value per share is Rs 10.

JSW Holdings is the investment arm of JSW Group.

Powered by Capital Market - Live News

Gulf Oil Lubricants gains after good Q2 result
Oct 21,2016

The result was announced after market hours yesterday, 20 October 2016.

Meanwhile, the S&P BSE Sensex was down 122.73 points or 0.44% at 28,004.93

On BSE, so far 6,949 shares were traded in the counter as against average daily volume of 3,621 shares in the past one quarter. The stock hit a high of Rs 774 and a low of Rs 745.75 so far during the day. The stock had hit a record high of Rs 780.40 on 7 October 2016. The stock had hit a 52-week low of Rs 452.10 on 21 March 2016. The stock had outperformed the market over the past 30 days till 20 October 2016, gaining 1.51% compared with 1.32% fall in the Sensex. The scrip also outperformed the market in past one quarter, advancing 25.02% as against Sensexs 1.17% rise.

The mid-cap company has equity capital of Rs 9.92 crore. Face value per share is Rs 2.

Gulf Oil Lubricants Indias earnings before interest, taxation, depreciation and amortization (EBITDA) rose 14% to Rs 44 crore in Q2 September 2016 over Q2 September 2015. The companys EBIDTA margins expanded by about 52 basis points on year on year basis to about 16.1% in Q2 September 2016 on the back of volume growth and steady margin.

Gulf Oil Lubricants India said that inspite of Q2 September 2016 quarter being seasonally a low offtake quarter due to the monsoons and reduced vehicle/equipment movements, the company achieved all round volume gains across segments to notch up overall double digit volume growth during the quarter.

Gulf Oil Lubricants India makes automotive and industrial lubricants, greases and 2-wheeler batteries. The company markets lubricants under the Gulf brand.

Powered by Capital Market - Live News

Oil E&P stocks decline along with fall in crude oil prices
Oct 21,2016

Meanwhile, the S&P BSE Sensex was down 132.02 points or 0.48% at 27,995.68.

Among oil exploration and production companies, Cairn India (down 1.44%), ONGC (down 1.31%) and Oil India (down 0.49%) declined. Lower crude oil prices would result in decrease in realizations from crude sales for oil exploration firms.

Reliance Industries fell 1.79% after consolidated net profit dropped 22.9% to Rs 7206 crore on 9.6% increase in turnover to Rs 81651 crore in Q2 September 2016 over Q2 September 2015. The result was announced after market hours yesterday, 20 October 2016.

Among public sector oil marketing companies, BPCL (up 0.85%), Indian Oil Corporation (IOCL) (up 0.54%) and HPCL (up 1.02%) edged higher.

Lower crude oil prices could decrease under-recoveries of PSU OMCs on domestic sale of LPG and kerosene at controlled prices. The government has already freed pricing of petrol and diesel. However, weakness is rupee raises cost of imports.

In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 66.8925, compared with closing of 66.81 during the previous trading session.

In global commodities markets, Brent crude oil futures extended losses as the dollar climbing to seven-month highs against a basket of currencies dragged down crude oil prices. Brent for December settlement was off 9 cents at $51.29 a barrel. The contract had dropped $1.29 a barrel or 2.44% to settle at $51.38 a barrel during previous trading session.

Powered by Capital Market - Live News

Foseco India drops after poor Q3 result
Oct 21,2016

The result was announced after market hours yesterday, 20 October 2016.

Meanwhile, the BSE Sensex was down 131.26 points, or 0.47%, to 27,998.58

On BSE, so far 1,353 shares were traded in the counter, compared with an average volume of 227 shares in the past one quarter. The stock hit a high of Rs 1,519.95 and a low of Rs 1,451 so far during the day. The stock hit a record high of Rs 1,574 on 6 January 2016. The stock hit a 52-week low of Rs 1,070 on 1 March 2016. The stock had outperformed the market over the past 30 days till 20 October 2016, gaining 6.32% compared with 1.32% fall in the Sensex. The scrip also outperformed the market in past one quarter, advancing 9.02% as against Sensexs 1.17% rise.

The small-cap company has an equity capital of Rs 6.39 crore. Face value per share is Rs 10.

Foseco India offers the widest range of solutions for producing casting of the highest standards in terms of quality, surface finish, soundness, integrity and dimensional tolerance.

Powered by Capital Market - Live News

Syngene International hits record high after posting robust Q2 results
Oct 21,2016

The result was announced after market hours yesterday, 20 October 2016.

Meanwhile, the S&P BSE Sensex was down 135.11 points, or 0.49%, to 27,990.72.

High volumes were witnessed on the counter. On BSE, so far 65,911 shares were traded in the counter, compared with average daily volume of 31,445 shares in the past one quarter. The stock hit a high of Rs 565 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 546.05 so far during the day. The stock hit a 52-week low of Rs 343.70 on 9 November 2015. The stock had outperformed the market over the past one month till 20 October 2016, rising 14.88% compared with 1.38% decline in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 28.49% as against Sensexs 0.77% rise.

The mid-cap company has equity capital of Rs 200 crore. Face value per share is Rs 10.

Syngene Internationals earnings before interest, taxes, depreciation and amortization (EBITDA) rose 49% to Rs 122 crore in Q2 September 2016 over Q2 September 2015. EBITDA margin rose to 38% in Q2 September 2016 from 31% in Q2 September 2015.

Promoted by Biocon, Syngene International is a leading India-based contract research organization (CRO) offering a suite of integrated and end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors. Biocon holds 72.61% stake in Syngene, as per the shareholding pattern as on 30 September 2016.

Powered by Capital Market - Live News

Biocon scales record high after turnaround Q2 outcome
Oct 21,2016

The result was announced after market hours yesterday, 20 October 2016.

Meanwhile, the S&P BSE Sensex was down 138 points or 0.49% at 27,991.84

On BSE, so far 2.23 lakh shares were traded in the counter as against average daily volume of 1.67 lakh shares in the past one quarter. The stock hit a high of Rs 1,020 so far during the day, which is also a record high for the stock. The stock hit a low of Rs 978 so far during the day. The stock had hit a 52-week low of Rs 430.80 on 12 February 2016. The stock had outperformed the market over the past 30 days till 20 October 2016, gaining 3.48% compared with 1.32% fall in the Sensex. The scrip also outperformed the market in past one quarter, advancing 21.21% as against Sensexs 1.17% rise.

The large-cap company has equity capital of Rs 100 crore. Face value per share is Rs 5.

Biocons consolidated total income rose 21.2% to Rs 992.50 crore in Q2 September 2016 over Q2 September 2015. Consolidated earnings before interest, taxation, depreciation and amortization (EBITDA) rose 45% to Rs 277 crore in Q2 September 2016 over Q2 September 2015. EBITDA margin improved to 28% in Q2 September 2016 from 23% in Q2 September 2015.

Biocon said that the company reported robust performance led by a strong growth of Small Molecules, Biologics and Syngene. Licensing income stood at Rs 32 crore while other income reported was Rs 52 crore in Q2 September 2016.

Commenting on the quarterly performance and highlights, Chairperson and Managing Director, Kiran Mazumdar-Shaw stated that the companys performance in Q2 September 2016, was led by strong growth across small molecules, biologics and research services. Expansion of biologics footprint in emerging markets and licensing agreements boosted the revenue further. The companys ready-to-use Insulin Glargine pen launched in Japan has been well received which augurs well for business. The acceptance of proposed biosimilar Trastuzumab filing for review by EMA was a critical milestone in Q2 September 2016. She added that long term investments in R&D, manufacturing facility in Malaysia and clinical advancement of programs will enable the company to unlock greater value, going forward.

Biocon is Indias largest and fully-integrated, innovation-led biopharmaceutical company.

Powered by Capital Market - Live News

Praj Industries drops after announcing weak Q2 results
Oct 21,2016

The result was announced after market hours yesterday, 20 October 2016.

Meanwhile, the S&P BSE Sensex was down 129.29 points or 0.46% at 28,001.20.

On BSE, so far 2.98 lakh shares were traded in the counter as against average daily volume of 2.04 lakh shares in the past one quarter. The stock hit a high of Rs 83.10 and a low of Rs 79.45 so far during the day. The stock had hit a 52-week high of Rs 105.15 on 4 July 2016. The stock had hit a 52-week low of Rs 70.40 on 26 February 2016. The stock had underperformed the market over the past one month till 20 October 2016, declining 1.83% compared with 1.38% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 8.02% as against Sensexs 0.77% rise.

The mid-cap company has equity capital of Rs 35.68 crore. Face value per share is Rs 2.

Praj Industries consolidated order backlog as on 30 September 2016 stood at Rs 1025 crore, which comprised 72% orders from domestic market.

Praj Industries offers innovative solutions for beverage alcohol and bioethanol plant, brewery, water & wastewater treatment plant, critical process equipment and systems and bioproducts.

Powered by Capital Market - Live News

HCL Tech gains after retaining revenue growth guidance for FY 2017
Oct 21,2016

The result was announced before market hours today, 21 October 2016.

Meanwhile, the S&P BSE Sensex was down 135.88 points or 0.48% at 27,993.96.

On BSE, so far 1.15 lakh shares were traded in the counter as against average daily volume of 1.58 lakh shares in the past one quarter. The stock hit a high of Rs 848.70 and a low of Rs 822 so far during the day. The stock had hit a 52-week high of Rs 889.80 on 1 February 2016. The stock had hit a 52-week low of Rs 706.50 on 11 May 2016. The stock had outperformed the market over the past one month till 20 October 2016, rising 2.91% compared with 1.38% decline in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 11.77% as against Sensexs 0.77% rise.

The large-cap company has equity capital of Rs 282.18 crore. Face value per share is Rs 2.

HCL Technologies consolidated net profit fell 1.6% to Rs 2014 crore on 1.6% growth in revenue to Rs 11519 crore in Q2 September 2016 over Q1 June 2016. Revenue in constant currency rose 2.8% in Q2 September 2016 over Q1 June 2016. The company expects revenue growth between 12% to 14% in constant currency terms in the current financial year ending 31 March 2017 (FY 2017). This translates into 11% to 13% growth in dollar terms based on 30 September 2016 exchange rates. HCL Technologies expects its operating margin (EBIT) to be in the range of 19.5% to 20.5% for FY 2017.

HCL Technologies announced that the board of directors of the company declared an interim dividend of Rs 6 per share for FY 2017.

HCL Technologies CFO Anil Chanana said the conversion of net income to operating cash flow has been in excess of 100% for last twelve months ended 30 September 2016 while the return on equity continues to be robust at 28%.

HCL Technologies announced that C. Vijayakumar, Chief Operating Officer of the company has been elevated to the position of the President and Chief Executive Officer of the company with effect from 20 October 2016. Anant Gupta has decided to leave the company to pursue personal interests outside of HCL.

Separately, HCL Technologies before market hours today, 21 October 2016 announced that it has entered into an agreement to acquire Butler America Aerospace, LLC (Butler Aerospace), a provider of engineering, design services and aftermarket engineering services to US Aerospace and Defense customers. Butler Aerospace is a wholly owned subsidiary of Butler America LLC. The proposed acquisition will exclude the staffing business of Butler America Inc. The consideration for the proposed transaction is $85 million to be paid in cash. The acquisition is subject to regulatory approvals including CFIUS approval in the US, along with other customary closing conditions. It is expected to be completed by 31 December 2016.

Butler Aerospace had revenues of $85.4 million for the year ended 31 December 2015 at earnings before interest and tax (EBIT) of 12.2%. The acquisition when consummated is likely to be EPS accretive, HCL Technologies said. Butler Aerospace serves customers primarily in the Aerospace and Defense industries in the US, to whom it provides engineering & design services in the areas of mechanical and structural design, electrical design, tool design and aftermarket engineering services. With over 900 highly skilled engineers and 7 design centers in the US, Butler Aerospace has a marquee list of clients in the Aerospace & Defense industries and works with OEMs and their suppliers. The acquisition will bolster HCLs capabilities in this space and access to clients with large R&D spends.

HCL Technologies is a leading global IT services company working with clients in the areas that impact and redefine the core of their businesses.

Powered by Capital Market - Live News